Patents by Inventor Shashi Kumar Gupta

Shashi Kumar Gupta has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • LNCRNA MEG3 for therapy and diagnosis of cardiac remodelling
    Patent number: 11186838
    Abstract: The present invention relates to a compound inhibiting the expression and/or the activity of maternally expressed 3 (Meg3) for use in treating or preventing cardiac remodelling.
    Type: Grant
    Filed: April 26, 2017
    Date of Patent: November 30, 2021
    Assignee: MEDIZINISCHE HOCHSCHULE HANNOVER
    Inventors: Thomas Thum, Maria-Teresa Piccoli, Janika Viereck, Shashi Kumar Gupta
  • The LNCRNA MEG3 for Therapy and Diagnosis of Cardiac Remodelling
    Publication number: 20190136236
    Abstract: The present invention relates to a compound inhibiting the expression and/or the activity of maternally expressed 3 (Meg3) for use in treating or preventing cardiac remodelling.
    Type: Application
    Filed: April 26, 2017
    Publication date: May 9, 2019
    Inventors: Thomas THUM, Maria-Teresa PICCOLI, Janika VIERECK, Shashi Kumar GUPTA
  • miRNA-212/132 family as a therapeutic target
    Patent number: 9388411
    Abstract: The present invention refers to inhibitors of microRNAs, particularly of microRNAs miR-212 and/or miR-132 for use in medicine, particularly in the diagnosis, treatment or prevention of cardiac disorders, e.g. cardiac hypertrophy-associated or autophagic disorders, and further refers to isolated nucleic acid molecules, particularly microRNAs miR-212 and/or miR-132 and related sequences, for use in medicine, particularly human medicine, more particularly in the diagnosis, treatment or prevention of disorders involving cardiac atrophy and/or dysfunctional autophagy, e.g. cardiac cachexia.
    Type: Grant
    Filed: September 6, 2012
    Date of Patent: July 12, 2016
    Assignees: Max-Planck-Gesellschaft zur Foerderung der Wissenschaften e.V., Medizinische Hochschule Hannover
    Inventors: Thomas Thum, Kamal Chowdhury, Ahmet Ucar, Shashi Kumar Gupta
  • THE miRNA-212/132 FAMILY AS A THERAPEUTIC TARGET
    Publication number: 20140275220
    Abstract: The present invention refers to inhibitors of microRNAs, particularly of microRNAs miR-212 and/or miR-132 for use in medicine, particularly in the diagnosis, treatment or prevention of cardiac disorders, e.g. cardiac hypertrophy-associated or autophagic disorders, and further refers to isolated nucleic acid molecules, particularly microRNAs miR-212 and/or miR-132 and related sequences, for use in medicine, particularly human medicine, more particularly in the diagnosis, treatment or prevention of disorders involving cardiac atrophy and/or dysfunctional autophagy, e.g. cardiac cachexia.
    Type: Application
    Filed: September 6, 2012
    Publication date: September 18, 2014
    Applicants: Medizinische Hochschule Hannover, Max-Planck-Gesellschaft zur Foerderung der Wissenschaften e.V.
    Inventors: Thomas Thum, Kamal Chowdhury, Ahmet Ucar, Shashi Kumar Gupta